4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-060047
Chief Scientific Officer sold 31,250 shares at an average $69.06 ($2,158,125)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bradshaw Curt Chief Scientific Officer | 2020-11-19 | Sale | −15,625 | $69.39 | $1,084,219 | 15,625 | D |
| Bradshaw Curt Chief Scientific Officer | 2020-11-20 | Sale | −15,625 | $68.73 | $1,073,906 | 0 | D |
| Open-market sales · 31,250 sh · avg $69.06 · $2,158,125 | |||||||
Loading xslF345X03/doc4.xml…